HSBC Holdings
CABA icon

HSBC Holdings’s Cabaletta Bio CABA Stock Holding History

HSBC Holdings’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,227
Closed -$14K – 2951
2022
Q2 		$14K Sell
13,227
-1,836
-12% -$2.6K ﹤0.01% 3205
2022
Q1 		$31K Sell
15,063
-8,523
-36% -$22.3K ﹤0.01% 3221
2021
Q4 		$91K Sell
23,586
-3,456
-13% -$36.9K ﹤0.01% 3158
2021
Q3 		$334K Sell
27,042
-13,895
-34% -$128K ﹤0.01% 2481
2021
Q2 		$344K Buy
40,937
+2,584
+7% +$25.4K ﹤0.01% 2424
2021
Q1 		$422K Buy
38,353
+14,095
+58% +$172K ﹤0.01% 2089
2020
Q4 		$292K Sell
24,258
-3,463
-12% -$44.9K ﹤0.01% 2583
2020
Q3 		$305K Buy
27,721
+10,037
+57% +$115K ﹤0.01% 2245
2020
Q2 		$197K Buy
+17,684
New +$135K ﹤0.01% 2377

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HSBC Holdings's CABA Position: Q3 2022 in Review

HSBC Holdings sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 13,227 shares — an estimated $14K sold.

HSBC Holdings first reported a position in CABA in Q2 2020 and held it in 9 quarters. The position peaked at $422K in Q1 2021. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

  • HSBC Holdings reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 13,227 Cabaletta Bio shares in Q3 2022, an estimated $14K.
  • HSBC Holdings first reported a position in Cabaletta Bio in Q2 2020 and held it in 9 quarters.
  • HSBC Holdings's Cabaletta Bio position peaked at $422K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.